More studies are needed to clearly evaluate whether PARP inhibits or stimulates tumor cell progression pathways and assess simultaneously the vasoactive effect, but no earlier study was conducted regarding the investigation of the PARPi treatment of VEGF expression levels in Pca cells. The gene discussed is PARP1; the disease is posterior cortical atrophy.